Keywords: boehringer, tipranavir, effective, resistant, hiv, ingelheim, germany

Boehringer's tipranavir effective in resistant HIV

Article | 15 July 2002

Print This

Boehringer Ingelheim of Germany's non-peptidic HIV protease inhibitortipranavir has been shown to have efficacy when used as part of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in